Carmell Therapeutics Corp (CTCX) USD0.0001 A

Sell:$0.30Buy:$0.31$0.01 (1.73%)

Prices delayed by at least 15 minutes
Sell:$0.30
Buy:$0.31
Change:$0.01 (1.73%)
Prices delayed by at least 15 minutes
Sell:$0.30
Buy:$0.31
Change:$0.01 (1.73%)
Prices delayed by at least 15 minutes

Company Information

About this company

Carmell Corporation (Carmell) is a bio-aesthetics company focused on skin and hair health. The Company utilizes the Carmell Secretome to support skin and hair health. The Carmell Secretome consists of a potent cocktail of growth factors and proteins extracted from allogeneic human platelets sourced from United States Food and Drug Administration-approved tissue banks. The Company has developed a novel micellar nanoparticle formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the harmful excipients that are used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. Additionally, Carmell’s micellar formulations do not utilize mineral or vegetable oils across their entire product line and are designed to be non-comedogenic. The Company is also developing a line of men’s products and a line of topical haircare products.

Key people

Rajiv Sarman Shukla
Executive Chairman of the Board, Chief Executive Officer
Bryan Cassaday
Chief Financial Officer
Patrick A. Sturgeon
Director
David Anderson
Independent Director
Scott Frisch
Independent Director
Kathryn Gregory
Independent Director
Gilles Spenlehauer
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US1429221039
  • Market cap
    $13.07m
  • Employees
    9
  • Shares in issue
    30.12m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.